The cul-de-sac at the end of the road

Journal of Cardiac Failure

Volumn 9, Issue 3, 2003, Pages 188-191

  Stevenson, Lynne Warner ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; HYDRALAZINE; INOTROPIC AGENT; MILRINONE; NITRATE; RENIN; SODIUM; VASODILATOR AGENT;

CLINICAL TRIAL; DRUG DEPENDENCE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; HYPOTENSION; KIDNEY DYSFUNCTION; MYOCARDITIS; NOTE; PRIORITY JOURNAL; SURVIVAL;

EID: 0037937453     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1054/jcaf.2003.41     Document Type: Note

References (16)

1. VMAC Study Group. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA 2002;287:1531-40.
2. Cuffe MS, Califf RM, Adams KF Jr, Benza R, Bourge R, Colucci WS, et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA 2002;287:1541-7.
3. Nohria A, Tsang S, Fang J, Lewis E, Jarcho J, Mudge G, et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol. In press 2003.
4. Rose EA, Gelijns A, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Long-term Use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001;345:1435-43.
5. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2001;38:2101-13.
6. Stevenson LW, Dracup KA, Tillisch JH. Efficacy of medical therapy tailored for severe congestive heart failure in patients transferred for urgent cardiac transplantation. Am J Cardiol 1989;63:461-4.
7. Lucas C, Johnson W, Hamilton MA, Fonarow GC, Woo MA, Flavell CM, et al. Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am Heart J 2000;140:840-7.
8. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med 1987;316:1429-35.
9. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303-10.
10. Fonarow GC, Chelimsky-Fallick C, Stevenson LW, Luu M, Hamilton MA, Moriguchi JD, et al. Effect of direct vasodilation with hydralazine: versus angiotensinconverting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial. J Am Coll Cardiol 1992;19:842-50.
11. Fernandez-Gonzalez AL, Panizo-Santos A. Eosinophilic myocarditis in heart transplant candidates. J Heart Lung Transplant 1996;15:852-3.
12. Young JB, Moen EK. Outpatient parenteral inotropic therapy for advanced heart failure. J Heart Lung Transplant 2000;19:S49-57.
13. Miller LW. Outpatient dobutamine for refractory congestive heart failure: advantages, techniques, and results. J Heart Lung Transplant 1991;10:482-7.
14. Lowes BD, Higginbotham M, Petrovich L, DeWood MA, Greenberg MA, Rahko PS, et al. Low-dose enoximone improves exercise capacity in chronic heart failure. Enoximone Study Group. J Am Coll Cardiol 2000;36:501-8.
15. Young JB. Refractory heart failure. Curr Cardiol Rep 1999;1:67-81.
16. Lewis EF, Johnson PA, Johnson W, Collins C, Griffin L, Stevenson LW. Preferences for quality of life or survival expressed by patients with heart failure. J Heart Lung Transplant 2001;20:1016-24.